youngStartup Ventures VC Outlook | Bio
By · CommentsyoungStartup is one of my favorite organizations that promotes connections between VCs and entrepreneurs. Wednesday, March 10 was their “VC Outlook” event for both tech and bio. The group is run by founder Joe Benjamin and I had the pleasure of volunteering for the life sciences portion which was also organized by Adam Negnewitzky, Joe’s Senior Associate.
Before I mention the VCs that were there and the interesting topics that came up, I have to gush a little about the other volunteers I met. youngStartup puts on the type of conference where it’s easy to strike up conversation with those around you. I built an entire network with the other volunteers within my first five minutes helping out at the registration table. I have to say, Adam has an army of helpers that are passionate about VC and entrepreneurship. I met some great people from Columbia, Ross, and other schools. There was even another InSITE Fellow, Jon Cooper, volunteering there, as well one of my Stern classmates, Steve Estes (all three of us had skipped VC-related classes to attend a VC conference, which I found pretty ironic. I guess that’s entrepreneurial spirit for you).
The life sciences panel included: Brandon Hull (Cardinal Partners), Noah Kroloff (NGN Capital), Andrew Schneider (Holtz Rubenstein Reminick LLP), Robert Seltzer (Care Capital), Anthony Sun (Aisling Capital), Nicole Vitullo (Domain Associates), and Kevin Collins (Goodwin Procter LLP) as moderator.
Much of the discussion was driven by audience questions, so naturally some topics came up that are common at other bio/pharma-related VC forums (healthcare reform, trouble forming syndicates in the current market, etc). I’ll try to list a couple that I thought were unique to this discussion in particular.
One interesting comment was about business development in Big Pharma. Yes, we all know Big Pharma has a lot of cash, and yes we all know that just because Big Pharma has a lot of cash it doesn’t mean they’ll buy just anything. But there was an observation about how start-ups gain champions within the pharma BD department.
It was observed that there is a bimodal approach to how acquisitions get pushed through the BD department: If you’re a young person in pharma BD, you are willing to champion something and push your company to buy it. In this case, your reputation isn’t on the line because the risky acquisition target still has 10 years development time left and there won’t be any noticeable failures in the near term.
In the second situation, you’re a more established, older BD professional and you only champion acquisitions that have drugs that have already been approved. In this case it’s safer and poses less risk to your career. The panel noted that they see less deals fall into the middle of these two approaches, thus the “bimodal” aspect of pharma deals.
Another interesting topic that came up was the issue of tech transfer. You thought healthcare reform was controversial? There was definitely some thick tension in the room when this topic came up. Why is tech transfer too spotty? One entrepreneur hotly noted, “We have SBIR grants and other grants that validate our science, but universities will show favor to other, less developed ideas with unproven science. Why?” Heads nodded in the room. Good point.
The answer seems to be that simply, some universities are better at this than others. Some are organized, well-run machines while others are spotty and don’t seem to have “best practices” that they follow. This problem feeds into overall VC environments, helping to explain why some cities become spin out powerhouses while other cities with high caliber of universities, do not.
More information: youngStartup Ventures
– Marisa Tricarico
Spring 2010 Alumni Advising Event
By · CommentsEach semester, after the teams and their companies have had a few meetings to refine their concepts and pitches, InSITE hosts an Alumni Advising Event. The aim of the event is to invite former InSITE fellows to hear the pitches, offer feedback, and meet our current roster of entrepreneurs and fellows.
This semester’s event was held on Tuesday, February 25, at Wilson Sonsini Goodrich & Rosati. We tried a different format this time: in the past we’ve had all of the current companies attend. Alumni would mill around from room to room, listening to pitches and giving on-the-spot feedback. This format gave the entrepreneurs the benefit of a rapid-fire set of reactions from multiple viewpoints and what was essentially a real-time dress rehearsal for their VC pitches. To experiment with a different structure this semester, however, we limited the event to the three Tuesday teams (Bandvest, Klickable, and ProtEquity), and encouraged our guests to narrow their focus to one or two of the teams.
Despite some seriously inclement weather, a few hardy alumni were undeterred, and a number of InSITE execs, senior fellows, and Wednesday team members came out as well.
Mike Kasdan (2001 alum), an intellectual property lawyer at Amster, Rothstein & Ebenstein, joined the Klickable team, along with Wednesday team members Ben Zhuk and Sean Weinstock. Senior fellows and execs sat in as well: Rob Schneider, Katherine Chung, and me (Tim Cohan).
Mike was kind enough to give us his thoughts on the event from the alumni perspective: “It was a great opportunity to reconnect and brainstorm with the team to help refine the Klickable pitch. It was also a great reminder of what I had loved about InSITE as a student participant – working with smart, motivated people, who bring a variety of skill-sets and perspectives to the table, to assist real entrepreneurs to build cutting edge businesses.” Team leader Mike Dibenedetto, who kept the meeting focused and moving along, was pleased to have Mike’s input; he says generally that the alumni feedback was “invaluable…it gave us a chance to hear what was working and what wasn’t from people who had deep experience with pitching entrepreneurial ventures.”
Molly Siems (InSITE 2007) brought her media interests and expertise to Bandvest, a company she sees as “super promising;” according to Kat Chung, Molly’s contributions garnered rave reviews among the team. “We heart Molly” was apparently the consensus. Of course, the benefits of reaching out to alumni clearly run both ways; Molly says that she’s “really grateful to have such an awesome network of people to bounce ideas off of and definitely get as much as I give.” Special thanks also to Marisa Tricarico (a Wednesday team member who just can’t stay away from an InSITE event), who lent her feedback to the Bandvest team as well. Following up with his thoughts on the event, team leader Dan Harman notes that Marisa and Molly’s input and suggestions were “invaluable.”
Along with alum Sam Sagalnik, InSITE Chairman Paul Tumpowsky lent his input to the ProtEquity, which he describes as “a very interesting company… a true financial technology firm, an ideal fit for the New York City venture ecosystem.” Paul adds that he’s confident that with the assistance of the InSITE team he saw in action, “ProtEquity will be able to articulate its unique and valuable solution in a competitive and ever-changing space.”
The happy hour at Cassidy’s afterward was lively as usual, and gave us all a chance to relax and connect with the alumni in a more informal setting. We were pleased to see Vinay Patel and Geoff Reed (both InSITE 2009) made it out to have a drink and meet some of the new fellows as well.
Thanks again to the alumni and senior fellows that braved a cold, wet evening to join us. If any of those reading this have more thoughts on how it went, ideas for future alumni advising events, or people I’ve forgotten to note or thank, please post them here or email me at vp.internal@insiteny.org.
– Tim Cohan, VP Internal 2009-2010
InSITE Accepts 18 Fellows to Fall 2009 Class
By · CommentsThis semester, we received a record number of applications from the most talented group of people ever to be together in graduate school. InSITE is excited to annouced 18 terrific new Fellows – they are:
Jon Cooper, NYU MBA
Michael DiBenedetto, Columbia MBA
Seth Goldman, NYU MBA
Sharon Goswami, NYU JD
Daniel Harman, Columbia MBA
Omar Haroun, Columbia JD
Colleen Honigsberg, Columbia JD
Nick Hurley, NYU MBA
Camila Jimenez Villa, NYU MBA/MFA
Christopher Johnson, Columbia MBA
Mike Katz, Columbia MBA
Stephanie Palmeri, Columbia MBA
Greg Pennington, Columbia MBA
Brian Rothenberg, NYU MBA
Alex Shellhammer, NYU MBA
Maria Testani, Columbia MBA
Marisa Tricarico, NYU MBA
Shirley Xu, Columbia MBA
Bios for our new Fellows are available here.
